Question 1

What specific criteria do I need to meet to qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma clinical trial (NCT06210243). Contact the study team or your healthcare provider for specific answers.

Question 2

How does C752 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma clinical trial (NCT06210243). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of C752?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma clinical trial (NCT06210243). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma clinical trial (NCT06210243). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma clinical trial (NCT06210243). Contact the study team or your healthcare provider for specific answers.

Question 6

Can you explain the process of receiving CAR-T cell therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma clinical trial (NCT06210243). Contact the study team or your healthcare provider for specific answers.

What this study is about